The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will ...

IDEXX Laboratories, a healthcare supplier specializing in veterinary health diagnostics and research, is a potential high-performing compounder due to its wide-moat business model, anti-cyclical ...

Get the annual and quarterly balance sheets for IDEXX Laboratories, Inc. (I1DX34.SA) including details of assets, liabilities and shareholders’ equity.

IDEXX Laboratories is a leader in animal diagnostics, boasting strong recurring revenue and nearly 50% stock gains year-to-date. IDXX's innovation pipeline, robust cash position, and global reach ...

Organic Revenue Growth: 5% overall, driven by 4.5% in CAG Diagnostics, 7% in Water, and 4% in LPD. CAG Diagnostics Recurring Revenue: 4.5% organic growth, net of a 1.5% headwind from equivalent days.

Achieves third quarter revenue growth of 7% as reported and 6% organic, supported by CAG Diagnostics recurring revenue growth of 7% as reported and organic. Organic revenue growth supported by ...